Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Breaking & Recent News IMV Inc IMMR


Primary Symbol: T.IMV

Healthcare Technology Biotechnology Software - Application
IMV Inc. operates as a clinical-stage immuno-oncology company. The company develops a portfolio of therapies based on DPX, an immune-educating technology platform for treatment of solid and hematological cancers. The company’s lead drug candidate includes maveropepimut-S, a DPX-based immunotherapy that targets survivin-expressing cells that is Phase II clinical trials for diffuse large B cell... see more

Recent & Breaking News (TSX:IMV)

Immersion Corporation Announces Receipt of a Delinquency Compliance Alert Notice from Nasdaq

Business Wire December 26, 2025

Immersion Corporation Announces Significant Increase in Quarterly Dividend and Cooperation Agreement with Largest Shareholder

Business Wire December 8, 2025

Immersion Board Adopts Temporary Shareholder Rights Plan to Protect Long-Term Interests of All Shareholders

Business Wire November 10, 2025

Immersion Corporation Announces Receipt of a Delinquency Compliance Alert Notice from Nasdaq

Business Wire October 2, 2025

Immersion Corporation Announces Receipt of a Delinquency Compliance Alert Notice from Nasdaq

Business Wire August 22, 2025

Immersion Corporation Reports Third Quarter of Fiscal 2025 Results

Business Wire March 12, 2025

Immersion Corporation Reports Second Quarter of Fiscal 2025 Results

Business Wire December 16, 2024

Immersion Corporation Reports Second Quarter 2024 Results

Business Wire August 20, 2024

Immersion Signs License Agreement with Samsung Electronics Co.

Business Wire May 22, 2024

Immersion Corporation Reports First Quarter 2024 Results

Business Wire May 8, 2024

Immersion Corporation Reports Fourth Quarter and Full Year 2023 Results

Business Wire March 7, 2024

Immersion Signs License Agreement with Nintendo

Business Wire March 4, 2024

Immersion Signs License Agreement with Meta Platforms, Inc. (formerly known as Facebook, Inc.)

Business Wire February 14, 2024

Immersion Corporation Reports Third Quarter 2023 Results

Business Wire November 13, 2023

Immersion Signs License Agreement with Razer

Business Wire November 2, 2023

Vishay Intertechnology Signs Agreement With Immersion to Bundle Haptic Technology Licenses With IHPT Series Actuators

GlobeNewswire August 22, 2023

Immersion Corporation Reports Second Quarter 2023 Results

Business Wire August 11, 2023

Immersion Files Complaint Against Valve in U.S. District Court for the Western District of Washington

Business Wire May 16, 2023

Immersion Corporation Reports First Quarter 2023 Results

Business Wire May 10, 2023

Immersion Signs License Agreement with Motrex for Automotive Interfaces

Business Wire April 6, 2023

Podcasts